Metraipolis › archive › dc_8504cb71a2d5

Combined Treatment with Evogliptin and Temozolomide Alters miRNA Expression but Shows Limited Additive Effect on Glioma — Europe PMC PMID:41096775

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41096775
DOI
10.3390/ijms26199508
License (as archived)
solo-consultazione
Archived
2026-11-09T17:40:22.681Z
SHA-256 of the archived text
f402a1dbfffd81bbf6a91d9e9225c408ed64823ea9bef71f41b2c1d1f7db1f11
Stable URL of this page
https://metraipolis.com/documento/dc_8504cb71a2d5

How to cite

Combined Treatment with Evogliptin and Temozolomide Alters miRNA Expression but Shows Limited Additive Effect on Glioma — Europe PMC PMID:41096775 — Europe PMC (en), https://europepmc.org/article/MED/41096775 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8504cb71a2d5 (Metraipolis archive dc_8504cb71a2d5, sha256 f402a1dbfffd81bbf6a91d9e9225c408ed64823ea9bef71f41b2c1d1f7db1f11)
BibTeX
@misc{dc8504cb71a2d5,
  title = {Combined Treatment with Evogliptin and Temozolomide Alters miRNA Expression but Shows Limited Additive Effect on Glioma — Europe PMC PMID:41096775},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41096775},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8504cb71a2d5; sha256 f402a1dbfffd81bbf6a91d9e9225c408ed64823ea9bef71f41b2c1d1f7db1f11},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41096775. Agents can read the archived copy with the MCP tool read_document.